Treatment Patterns of Long-Acting Somatostatin Analogs for Neuroendocrine Tumors
**Background:** Long-acting somatostatin analog therapy (LA-SSA) is recommended as first-line therapy for treatment of unresectable or metastatic neuroendocrine tumors (NETs). Understanding treatment sequencing and dosing patterns of LA-SSA is essential for clinical decision-making to provide value-...
Saved in:
Main Authors: | Callisia N. Clarke, Paul Cockrum, Thomas J.R. Beveridge, Michelle Jerry, Donna McMorrow, Anh Thu Tran, Alexandria T. Phan |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2023-12-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.89300 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Somatostatin Analogs in the Medical Management of Occult Bleeding of the Lower Digestive Tract
by: Julie Martin-Grace, et al.
Published: (2015-01-01) -
Antitumoral and Anti-inflammatory Roles of Somatostatin and Its Analogs in Hepatocellular Carcinoma
by: Argyrios Periferakis, et al.
Published: (2021-01-01) -
Somatostatin Treatment for Ectopic ACTH Syndrome due to Pancreatic Neuroendocrine Tumors: Review of the Literature
by: Da Zhang, et al.
Published: (2022-01-01) -
Somatostatin in inflammatory bowel disease
by: J. D. Van Bergeijk, et al.
Published: (1997-01-01) -
Erratum to “Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study”
by: Ming Shen, et al.
Published: (2019-01-01)